pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
VMT-01
Metastatic Melanoma
$CATX
Perspective Therapeutics, Inc.
Phase 2
VMT-a-NET
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
$CATX
Perspective Therapeutics, Inc.
Preclinical
VNLG-152
Triple-Negative Breast Cancer (TNBC)
Isoprene Pharmaceuticals Inc
Phase 2
← prev
page 38 of 62
next →
Pain
89
Neurology
1
VNX-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
Vironexis Biotherapeutics Inc
Phase 2
VNX-202
Gastric Cancer
Vironexis Biotherapeutics Inc
Phase 2
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
Preclinical
VTRU-200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Vitruviae LLC
Preclinical
VV-169
Refractory Multiple Myeloma
$NVS
NOVARTIS AG
Phase 1
VVD-037
Solid Tumor
Vividion Therapeutics Inc
Phase 1
VVD-850
Non-Small Cell Lung Cancer
Vividion Therapeutics Inc
Preclinical
VXAHPV-16.1
Human Papillomavirus (HPV) Associated Cancer
$VXRT
Vaxart, Inc.
Phase 2
VXM-01
Recurrent Glioblastoma Multiforme (GBM)
Vaximm AG
Preclinical
Vaccine for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer (TNBC)
Flow Pharma Inc
Preclinical
Vaccine to Target IL15, IL15RA and CD80 for Acute Myeloblastic Leukemia
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
University of California San Francisco
Phase 2
WP-1066
Glioblastoma Multiforme (GBM)
$MBRX
Moleculin Biotech, Inc.
Preclinical
WSD-0329
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
Phase 1
WSD-0628
Astrocytoma
Wayshine Biopharma Inc
Phase 2
WSD-0922
Non-Small Cell Lung Cancer
Wayshine Biopharma Inc
Preclinical
WSD-1227
Glioblastoma Multiforme (GBM)
Wayshine Biopharma Inc
Phase 2
WTX-330
Colorectal Cancer
$HOWL
Werewolf Therapeutics, Inc.
Phase 1
XB-010
Endometrial Cancer
$EXEL
EXELIXIS, INC.
Phase 1
XB-371
Solid Tumor
$EXEL
EXELIXIS, INC.
Phase 1
XB-628
Solid Tumor
$EXEL
EXELIXIS, INC.
Preclinical
XBIO-020
Hematological Tumor
$XBIO
Xenetic Biosciences, Inc.
Phase 1
XKH-002
Solid Tumor
Zhejiang Xinkanghe Biomedical Technology Co Ltd
Phase 1
XL-309
Fallopian Tube Cancer
$EXEL
EXELIXIS, INC.
Preclinical
XLNT-1
Metastatic Ovarian Cancer
Nami Therapeutics Corp
Preclinical
XM-14601
Pancreatic Ductal Adenocarcinoma
Excellamol Inc
Preclinical
XM-161SN38
High-Grade Glioma
Excellamol Inc
Preclinical
XTX-501
Non-Small Cell Lung Cancer
$XLO
Xilio Therapeutics, Inc.
